This is a community-generated profile. If you would like to claim it, please .
Gilead Sciences
Develops and commercializes medicines for life-threatening diseases5000+ EmployeesActively Hiring
Gilead Sciences Funding
$3.5M
11 round
Gilead Sciences is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $3.5M. Their most recent funding was raised on November 13, 2024.
Funding Rounds
S
$3500000Investors of Gilead Sciences
Eric Walker
Value investor in Public and Private Companies; founder, cofounder & cocrerator
Josh Kaplan
Growth-oriented, charismatic teammate.